Iovance Biotherapeutics Inc. Common Stock vs Regions Financial Corporation Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B), while Regions Financial Corporation Common Stock trades at $27.04 (market cap $22.75B). The key difference: Regions Financial Corporation Common Stock is far larger — about 3.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Regions Financial Corporation Common Stock pays a 4.1% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Regions Financial Corporation Common Stock for 0 Days on average.
| IOVA | RF | |
|---|---|---|
Market Cap | $5.85B | $22.75B |
Volume | 14,517,176 | 8,730,639 |
Sector | Health | Financials |
52-Week High | $14.82 | $32.40 |
52-Week Low | $1.81 | $23.35 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.78B | $20.49B |
Dividend Yield | — | 4.1% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Regions Financial is a financial holding company that operates through Regions Bank. It provides consumer, commercial, mortgage, wealth-management, and investment services across the South, Midwest, and Texas.
Read more on RF →